Shedding new light on atherosclerosis therapeutics: Nanomedicines targeting atherosclerotic immune microenvironment

Atherosclerosis (AS) leads to atherosclerotic cardiovascular disease (ASCVD), the predominant cause of death worldwide. As traditional lipid-lowering therapies have encountered a bottleneck in dealing with diverse types of atherosclerotic plaques and ASCVD, alternative therapies that can target othe...

Full description

Saved in:
Bibliographic Details
Main Authors: Zhiyue Wang, Jie Sheng, Guangming Lu, Longjiang Zhang
Format: Article
Language:English
Published: Elsevier 2024-12-01
Series:EngMedicine
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2950489924000435
Tags: Add Tag
No Tags, Be the first to tag this record!